Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Sanofi and its subsidiary Genzyme report that following discussions with FDA,  the company plans to resubmit in the second quarter its supplemental biologics license application seeking approval of Lemtrada (alemtuzumab) for the treatment...

Impax Laboratories Inc. has appointed Jeffrey D. Nornhold as senior vice-president, technical operations and will oversee the company's manufacturing, supply chain, quality and technical operations. Nornhold previously served as the company's...

Baxter International Inc. has agreed to acquire all of the outstanding membership interests of Chatham Therapeutics for $70 million. As a result of the transaction, Baxter will acquire Chatham's developmental gene therapy programs directed toward...

Par Pharmaceutical Companies, Inc. has named Terrance J. Coughlin chief operating officer. In this capacity, Coughlin will be responsible for Par's global manufacturing activities, research and development efforts and will be instrumental in...

Eli Lilly and Company reports that the US District Court for the Southern District of Indiana has ruled in the company's favor regarding the vitamin dosage regimen patent for Alimta® (pemetrexed for injection). In the case of Eli Lilly...

Teva Pharmaceutical Industries Ltd. reports the US Supreme Court has granted the company's COPAXONE® certiorari petition and will hear its appeal of a decision from the United States Court of Appeals for the Federal Circuit that invalidated...

Eisai Inc., a subsidiary of Tokyo-based Eisai Co., Ltd announced the sale and assignment of its rights to a worldwide exclusive license for DACOGEN® (decitabine) for injection to Otsuka Pharmaceutical Co., Ltd., giving Otsuka full development and...

GlaxoSmithKline (GKS) announced a series of new investments in sub-Saharan Africa designed to address pressing health needs and contribute to long-term business growth. Speaking at the 5th EU-Africa Business Forum in Brussels, GSK CEO Sir Andrew...